Our Mission

Medicines are transforming our lives like never before.  We want the UK to be the best place in the world to research, develop and use the medicines of the future.

Our Objectives

To do this, we focus on:

  • Building a thriving environment for medicine discovery so the UK can be the best place in the world to research and develop new medicines and vaccines. 

  • Improving access to new medicines and vaccines so everyone in the UK can get the latest treatments.

  • Enhancing reputation by demonstrating the high ethical standards we set ourselves and that society expects from us.

  • Representing our members, using their insight and experience to tell the story of how they change the lives of millions of people every day

 


Leadership Team

Leadership Team

​​​​Biographies from the ABPI President, members of the ABPI Leadership Team and the Directors of the devolved nations.

ABPI Board

​​​As a member organisation, we are led by our members who are actively involved in all the core areas of our activity, as well as helping to form the strategy and direction for the ABPI.

ABPI Board
ABPI Northern Ireland

ABPI Northern Ireland

ABPI Northern Ireland was established in 2008 to support the development of life sciences in Northern Ireland and to ensure that the benefits of biomedical innovation are brought rapidly to patients.

ABPI Scotland

The ABPI opened an office in Edinburgh at the reconvening of the Scottish Parliament in 1999. The ABPI Scotland team works to represent the interests of our member companies to stakeholders here in Scotland.

ABPI Scotland
ABPI Cymru Wales

ABPI Cymru Wales

ABPI Cymru Wales was established in 2003 in response to the evolving distinctiveness of the post-devolution health and economic agenda in Wales.

Careers at ABPI

​​​​People who work for the ABPI make a difference. We are at the heart of a multi-billion pound pharmaceutical industry. Roles at the ABPI range from close liaison with Government and the NHS to working with education organisations and the media.